Skip to main content
Log in

1p/19q chromosome deletions in metastatic oligodendroglioma

  • Clinical Study-Patient Studies
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Extracranial metastasis of primary brain tumors is a rare phenomenon. Of the few cases reported of metastatic oligodendroglioma, only two have evaluated genetic alterations, specifically deletions of chromosomes 1p and 19q. Herein, we report two additional patients with metastatic anaplastic oligodendroglioma to bone, both followed until death. All available pathology specimens were reviewed and genetic analysis was performed in one of the cases. Although the bone metastasis was non-informative, the primary intracranial tumor revealed codeletions of the 1p and 19q chromosomal arms, commonly recognized as the genetically favorable profile of oligodendrogliomas. Both patients died of complications related to their systemic disease and did not have any radiologic evidence of intracranial progression at the time of their last MRI studies. Along with the reported literature, our data suggest that despite their generally favorable behavioral profiles, oligodendroglial tumors with 1p/19q deletions may be more prone to metastasis as they progress. Genetic analysis serves a valuable ancillary role in the diagnostic workup of such cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Engelhard HH, Stelea A, Mundt A (2003) Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis. Surg Neurol 60(5):443–456

    Article  PubMed  Google Scholar 

  2. Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG (2001) Trends in incidence of primary brain tumors in the United States, 1985–1994. Neuro-oncology 3:959–966

    Article  Google Scholar 

  3. Fortin D, Macdonald DR, Stitt L, Cairncross JG (2001) PCV for oligodendroglial tumors: in search of prognostic factors for response and survival. Can J Neurol Sci 28:215–223

    PubMed  CAS  Google Scholar 

  4. Chahlavi A, Kanner A, Peereboom D, Staugaitas SM, Elson P, Barnett G (2003) Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results. J Neurooncol 61:267–273

    Article  PubMed  Google Scholar 

  5. Morrison T, Bilbao JM, Guisheng Y, Perry JR (2004) Bony metastasis of anaplastic oligodendroglioma respond to temozolomide. Can J Neurol Sci 31:102–118

    PubMed  Google Scholar 

  6. Liwnicz BH, Rubinstein LJ (1979) The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature. Hum Pathol 10:453–467

    PubMed  CAS  Google Scholar 

  7. Macdonald DR, O'Brien RA, Gilbert JJ, Cairncross JG (1989) Metastatic anaplastic oligodendroglioma. Neurology 39:1593–1596

    PubMed  CAS  Google Scholar 

  8. Dawson TP (1997) Pancytopenia from a disseminated anaplastic oligodendroglioma. Neuropathol Appl Neurobiol 23:516–520

    Article  PubMed  CAS  Google Scholar 

  9. Perry A (2004) News in brief. metastatic oligodendroglioma: a mini-epidemic? Adv Anat Pathol 11:325

    Article  Google Scholar 

  10. Cairncross JG, Ueki K, Zlatescu C, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendroglioma. J Natl Cancer Inst 90(19):1473–1479

    Article  PubMed  CAS  Google Scholar 

  11. Ino Y, Betensky RA, Zlatescu C, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN (2001) Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis. Clin Cancer Res 7:839–845

    PubMed  CAS  Google Scholar 

  12. Giordana MT, Ghimenti C, Leonardo E, Balteri I, Iudicello M, Duo D (2004) Molecular genetic study of a metastatic oligodendroglioma. J Neurooncol 66:265–271

    Article  PubMed  CAS  Google Scholar 

  13. Fallon KB, Palmer CA, Roth K, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A (2004) Prognostic value of 1p, 19q, 9p, 10q and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol 63:314–322

    PubMed  CAS  Google Scholar 

  14. Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW (2003) Ancillary FISH analysis for 1p and 19q status : preliminary observations in 287 gliomas and oligodendroglioma mimics. Front Biosci 8:a1–a9

    PubMed  CAS  Google Scholar 

  15. Bigner DD, McLendon RE, Brunner JM (1998) Russell & Rubinsteinȁ9s pathology of tumors of the nervous system. 6th edn. Edward Arnold, London, pp518–522

    Google Scholar 

  16. Ho-Keung N, Sun D, Poon W (2001) Anaplastic oligodendroglioma with drop metastasis to the spinal cord. Clin Neuro Neurosurg 104:383–386

    Google Scholar 

  17. Smith JS, Perry A, Borell TJ, Lee HK, Oȁ9Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636–645

    PubMed  CAS  Google Scholar 

  18. Anand M, Kumar R, Paresh J, Gupta R, Ghosal N, Sharma A, Agarwal A, Sharma MC (2003) Metastatic anaplastic oligodendroglioma simulating acute leukemia. Acta Cytol 47:467–469

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cheryl Ann Palmer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merrell, R., Nabors, L.B., Perry, A. et al. 1p/19q chromosome deletions in metastatic oligodendroglioma. J Neurooncol 80, 203–207 (2006). https://doi.org/10.1007/s11060-006-9179-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-006-9179-0

Keywords

Navigation